http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2026, Vol. 35 ›› Issue (2): 187-197.DOI: 10.5246/jcps.2026.02.014

• 【研究论文】 • 上一篇    下一篇

构筑创新桥梁: 依托异地研究机构建设生物医药概念验证中心的战略路径

宋书香1,*(), 许迎利1, 王静1, 王上宁2, 侯昀含1   

  1. 1. 北京大学 药学院 天然药物及仿生药物全国重点实验室, 北京 100191
    2. 北京大学 宁波海洋药物研究院, 浙江 宁波 315832
  • 收稿日期:2025-12-01 修回日期:2025-12-28 接受日期:2026-01-07 出版日期:2026-03-05 发布日期:2026-03-05
  • 通讯作者: 宋书香

Building innovation bridges: a strategic pathway for establishing biomedical proof-of-concept centers based on off-site research institutions

Shuxiang Song1,*(), Yingli Xu1, Jing Wang1, Shangning Wang2, Yunhan Hou1   

  1. 1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China
    2. Ningbo Institute of Marine Drugs, Peking University, Ningbo 315832, Zhejiang, China
  • Received:2025-12-01 Revised:2025-12-28 Accepted:2026-01-07 Online:2026-03-05 Published:2026-03-05
  • Contact: Shuxiang Song
  • Supported by:
    The Management Research Project on the Transformation of Scientific and Technological Achievements at Peking University Health Science Center (Grant No. KT202501) and the 2025 General Research Project on Party Building of Peking University Health Science Center (No. 2).

摘要:

生物医药原始创新从实验室到市场面临高风险的“死亡之谷”, 而高校传统转化模式在功能定位和资源整合上存在局限。本文通过文献综述与案例研究, 提出依托异地研究机构建设专业化概念验证中心是破解该困境的有效路径。异地机构的制度灵活性、产业贴近性及功能复合性, 为概念验证活动提供了理想载体。本文构建了一个包含技术评估、资金支持、实验验证与商业赋能的四维功能模型, 并阐述了以“风险共担”为核心的市场化运行机制。最后, 从机构治理、政策协同与生态构建三方面提出建议, 以期为我国高校生物医药成果的高效转化提供理论参考与实践框架。

关键词: 生物医药, 成果转化, 概念验证中心, 异地研究机构, 死亡之谷

Abstract:

This study explores viable pathways for establishing biomedical proof-of-concept (POC) centers via university-affiliated, off-campus research institutions, with the specific aim of overcoming the persistent “valley of death” in biomedical technology translation. By integrating a systematic literature review with in-depth case analyses, the study delineates critical structural and institutional bottlenecks that impede the progression of biomedical discoveries from laboratory research to clinical and industrial application, while highlighting the comparative advantages of off-campus research entities as flexible and translationally oriented platforms. Building on these insights, we propose a four-dimensional functional framework encompassing technology evaluation, targeted financial support, experimental validation, and commercialization facilitation, supported by a market-oriented operational model grounded in risk-sharing mechanisms. Collectively, this integrated model promotes more effective linkage between academic innovation and industrial deployment through coordinated engagement of multiple stakeholders and policy instruments, offering both conceptual contributions and an actionable framework to enhance the efficiency of biomedical technology transfer within Chinese universities.

Key words: Biomedicine, Technology transfer, Proof-of-concept center, Off-site research institutions, Valley of death

Supporting: